These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Transcriptome Analysis of Two Strains of Proteus mirabilis with Swarming Migration Deficiency Isolated from Patients with Urinary Tract Infection. Peng L, Chen DQ, Jiang GM, Ou JY, Jiang Q, Zeng LT, Xiao Y, Jiang QY, Yang L, Ning Sun. Curr Microbiol; 2020 Aug; 77(8):1381-1389. PubMed ID: 32152756 [Abstract] [Full Text] [Related]
23. The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. Allison C, Emödy L, Coleman N, Hughes C. J Infect Dis; 1994 May; 169(5):1155-8. PubMed ID: 8169413 [Abstract] [Full Text] [Related]
24. Effect of Ibicella lutea on uropathogenic Proteus mirabilis growth, virulence, and biofilm formation. Sosa V, Zunino P. J Infect Dev Ctries; 2009 Dec 15; 3(10):762-70. PubMed ID: 20009277 [Abstract] [Full Text] [Related]
25. New aspects of RpoE in uropathogenic Proteus mirabilis. Liu MC, Kuo KT, Chien HF, Tsai YL, Liaw SJ. Infect Immun; 2015 Mar 15; 83(3):966-77. PubMed ID: 25547796 [Abstract] [Full Text] [Related]
26. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis. Mobley HL, Island MD, Massad G. Kidney Int Suppl; 1994 Nov 15; 47():S129-36. PubMed ID: 7869662 [Abstract] [Full Text] [Related]
27. Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression. Pearson MM, Yep A, Smith SN, Mobley HL. Infect Immun; 2011 Jul 15; 79(7):2619-31. PubMed ID: 21505083 [Abstract] [Full Text] [Related]
28. Transcriptome of swarming Proteus mirabilis. Pearson MM, Rasko DA, Smith SN, Mobley HL. Infect Immun; 2010 Jun 15; 78(6):2834-45. PubMed ID: 20368347 [Abstract] [Full Text] [Related]
29. Proteus mirabilis isolates of different origins do not show correlation with virulence attributes and can colonize the urinary tract of mice. Sosa V, Schlapp G, Zunino P. Microbiology (Reading); 2006 Jul 15; 152(Pt 7):2149-2157. PubMed ID: 16804188 [Abstract] [Full Text] [Related]
30. UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections. Dattelbaum JD, Lockatell CV, Johnson DE, Mobley HL. Infect Immun; 2003 Feb 15; 71(2):1026-30. PubMed ID: 12540589 [Abstract] [Full Text] [Related]
31. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide. Abdel-Baky RM, Ali MA, Abuo-Rahma GEAA, AbdelAziz N. Adv Exp Med Biol; 2017 Feb 15; 973():99-113. PubMed ID: 28190143 [Abstract] [Full Text] [Related]
32. Quantification of Urease Activity. Richmond S, Yep A. Methods Mol Biol; 2019 Feb 15; 2021():85-96. PubMed ID: 31309498 [Abstract] [Full Text] [Related]
33. Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections. Hola V, Peroutkova T, Ruzicka F. FEMS Immunol Med Microbiol; 2012 Jul 15; 65(2):343-9. PubMed ID: 22533980 [Abstract] [Full Text] [Related]
34. Clonal relatedness of Proteus mirabilis strains causing urinary tract infections in companion animals and humans. Marques C, Belas A, Aboim C, Trigueiro G, Cavaco-Silva P, Gama LT, Pomba C. Vet Microbiol; 2019 Jan 15; 228():77-82. PubMed ID: 30593384 [Abstract] [Full Text] [Related]
35. The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection. Jacobsen SM, Lane MC, Harro JM, Shirtliff ME, Mobley HL. FEMS Immunol Med Microbiol; 2008 Mar 15; 52(2):180-93. PubMed ID: 18194341 [Abstract] [Full Text] [Related]
36. Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation. Allison C, Coleman N, Jones PL, Hughes C. Infect Immun; 1992 Nov 15; 60(11):4740-6. PubMed ID: 1398984 [Abstract] [Full Text] [Related]
38. Growth, cellular differentiation and virulence factor expression by Proteus mirabilis in vitro and in vivo. Zunino P, Piccini C, Legnani-Fajardo C. J Med Microbiol; 1999 Jun 15; 48(6):527-534. PubMed ID: 10359301 [Abstract] [Full Text] [Related]
39. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. Mobley HL, Chippendale GR. J Infect Dis; 1990 Mar 15; 161(3):525-30. PubMed ID: 2179424 [Abstract] [Full Text] [Related]
40. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. Pearson MM, Sebaihia M, Churcher C, Quail MA, Seshasayee AS, Luscombe NM, Abdellah Z, Arrosmith C, Atkin B, Chillingworth T, Hauser H, Jagels K, Moule S, Mungall K, Norbertczak H, Rabbinowitsch E, Walker D, Whithead S, Thomson NR, Rather PN, Parkhill J, Mobley HL. J Bacteriol; 2008 Jun 15; 190(11):4027-37. PubMed ID: 18375554 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]